19 July | 16.00 BST | 17.00 CEST | 08.00 PT | 11.00 ET | Virtual

Driving Genome-Wide Consistency in Cellular Reprogramming

In this webinar, hosted by Technology Networks, Dr. Ania Wilczynska will discuss a new method for making human iPSC-derived cells, opti-oxTM  precision cellular reprogramming technology.  This technology synchronously reprograms iPSCs with remarkable genome-wide consistency.
Driving Genome-Wide Consistency in Cellular Reprogramming

Dr. Ania Wilczynska

Head of Computational Genomics, Non-Clinical

bit.bio

Driving Genome-Wide Consistency in Cellular Reprogramming
In this webinar, hosted by Technology Networks, Dr. Ania Wilczynska will discuss a new method for making human iPSC-derived cells, opti-oxTM  precision cellular reprogramming technology.  This technology synchronously reprograms iPSCs with remarkable genome-wide consistency.
Driving Genome-Wide Consistency in Cellular Reprogramming

Dr. Ania Wilczynska

Head of Computational Genomics, Non-Clinical

bit.bio

Biological variance poses challenges when using human iPSC-derived cells in vitro, leading to inconsistent experimental results and data variability.

In this webinar, Dr. Ania Wilczynska will discuss a new method for making human iPSC-derived cells, opti-ox  precision cellular reprogramming technology.  This technology synchronously reprograms iPSCs with remarkable genome-wide consistency. Through transcriptome analysis, Ania will demonstrate that opti-ox reprogrammed iPSC-derived cells show minimal biological variance between users, manufacturing lots and time periods.

You’ll discover how this long-term cellular consistency can enable researchers to investigate functions of genes or responses to various compounds in great detail, using a human-relevant model system.

Attend this webinar to:

  • Understand the factors impacting experimental variance when using iPSC-derived cells
  • Explore a new method of cell generation called opti-ox, which enables precise reprogramming of iPSCs into defined, functional cell types
  • Discover the impact of opti-ox technology on cell consistency
  • Hear how this technology has been used for consistent and precise reprogramming of iPSCs to glutamatergic neurons, GABAergic neurons, microglia and sensory neurons  
Register now

Related pages

News Read our latest updates and press coverage
Blog Learn more about cells, our products, company and culture
About us Find out more about us and our people